love Matt's response.. Can you say Confidence? Matt is getting better about mentioning thing to the average shareholder.. less room for speculation.. Matt.. thank you.. all I needed to hear!
wait.. I thought it was Roche... boy Sierra changes with the wind!
Cramer fan... wow .. that says it all.. an adult that has a need to say Booya!!! Wow.. just Wow!
and rode it to 50 and never sold.. that would be tough to handle.. just curious.. good luck
Gordo also said this.in quotes when some said a different company would buy out MNKD "You were close, but it's SNY at $56/share.".. ............ Gordo wass probably 18 months early on the buyout news...... but the 56 could be reached; not including Techno.
or $55 bucks a share.. I believe that.. but not until late 2015 early 2016.
why so sick of shorts.. if people didn't sell they wouldn't be boasting so much.. I think there are a lot of smart longs that sold at 10 + or even 9+.. lets be honest; when the stock was at 11 would you have sold thinking it would retrace 6.50... some people are good with trades.. personally I don't want the headache.. I will wait for B/O.
Finding old post where longs thought the stock would be higher and never look back... that's all they got.. They know they don't have any facts.. They know their days are numbered.. Is it in November, January or March.. doesn't matter cause it will happen.. btw.... the market looks three to six months ahead for where a stock should be.. so after Q1 earnings.. look out.. cause the market will be basing those earnings by December or January.
mnholdem, you know they will spin this as a "sale"!!!!! just a sale.. lol
that he was planning to sell MNKD (Afrezza) after a couple of quarters of sales and (yes he must include SNY on first bidding rights).. he probably didn't give a damn about the 35% for such a small period of time... . Sounds simple but then sometimes we overlook the easy things in life.
SF: Do you think this is a greater accomplishment than what you developed at MiniMed, because this can affect so many more people?
AM: In my view it will affect so many more people. If we can combine Afrezza with better basal insulins the combination will make an enormous difference that will certainly affect far more people than we could ever imagine. Indeed, some key opinion leaders are saying that Afrezza therapy in early stage type 2 diabetes should slow, probably stop and maybe even reverse type 2 diabetes. Today diabetes is the greatest need in medicine globally.
SNY wanted this statement in the contract because they know other Companies will be suiting MNKD.
I don't think Al came out today with this info because the stock price.. I think he was giving us the future.. and to not be fools and stick with the CO. (in his own way)
I'm not frustrated.. My hope was 25 bucks by Next spring all along.. What happens in between is inmaterial.